Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.1506 | 0.0839 | 0.5 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.093 | 0.0192 | 0.2291 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.1506 | 0.0839 | 0.5 |
Schistosoma mansoni | cytochrome P450 reductase | 0.1506 | 0.0839 | 1 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.1506 | 0.0839 | 0.5 |
Echinococcus multilocularis | thymidine phosphorylase | 0.9664 | 1 | 1 |
Giardia lamblia | Hypothetical protein | 0.1335 | 0.0647 | 0.5 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.1506 | 0.0839 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.1506 | 0.0839 | 1 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.1506 | 0.0839 | 0.066 |
Mycobacterium ulcerans | anthranilate phosphoribosyltransferase | 0.2728 | 0.2211 | 0.1498 |
Brugia malayi | FAD binding domain containing protein | 0.1506 | 0.0839 | 1 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.1506 | 0.0839 | 0.5 |
Mycobacterium leprae | Probable anthranilate phosphoribosyltransferase TrpD | 0.2728 | 0.2211 | 0.5 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.1506 | 0.0839 | 0.5 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.1506 | 0.0839 | 0.066 |
Chlamydia trachomatis | sulfite reductase | 0.093 | 0.0192 | 0.5 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.1506 | 0.0839 | 1 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.1335 | 0.0647 | 0.5 |
Trichomonas vaginalis | sulfite reductase, putative | 0.1506 | 0.0839 | 1 |
Trypanosoma cruzi | p450 reductase, putative | 0.1506 | 0.0839 | 0.5 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.1506 | 0.0839 | 0.5 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.1506 | 0.0839 | 0.5 |
Brugia malayi | flavodoxin family protein | 0.1506 | 0.0839 | 1 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.1506 | 0.0839 | 0.066 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.1506 | 0.0839 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1506 | 0.0839 | 1 |
Mycobacterium ulcerans | thymidine phosphorylase | 0.9664 | 1 | 1 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.1506 | 0.0839 | 0.066 |
Leishmania major | p450 reductase, putative | 0.1506 | 0.0839 | 1 |
Mycobacterium tuberculosis | Probable thymidine phosphorylase DeoA (tdrpase) (pyrimidine phosphorylase) | 0.9664 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
clogP | = 10.09 | Calculated partition coefficient (clogP) | ChEMBL. | 9632355 |
MIC (functional) | > 100 ug ml-1 | Minimal inhibitory concentration agianst Staphylococcus aureus | ChEMBL. | 9632355 |
MIC (functional) | > 100 ug ml-1 | Minimal inhibitory concentration agianst Streptococcus faecalis | ChEMBL. | 9632355 |
MIC (functional) | > 100 ug ml-1 | Minimal inhibitory concentration agianst Escherichia coli | ChEMBL. | 9632355 |
MIC (functional) | > 100 ug ml-1 | Minimal inhibitory concentration agianst Proteus vulgaris | ChEMBL. | 9632355 |
MIC (functional) | > 100 ug ml-1 | Minimal inhibitory concentration agianst Candida albicans | ChEMBL. | 9632355 |
MIC (functional) | > 100 ug ml-1 | Minimal inhibitory concentration agianst Saccharomyces cerevisiae | ChEMBL. | 9632355 |
MIC (functional) | > 100 ug ml-1 | Minimal inhibitory concentration agianst Aspergillus fumigatus | ChEMBL. | 9632355 |
MIC (functional) | > 100 ug ml-1 | Minimal inhibitory concentration agianst Aspergillus niger | ChEMBL. | 9632355 |
MIC (functional) | > 100 ug ml-1 | Minimal inhibitory concentration agianst Mucor mucedo | ChEMBL. | 9632355 |
MIC (functional) | > 100 ug ml-1 | Minimal inhibitory concentration agianst Escherichia coli | ChEMBL. | 9632355 |
MIC (functional) | > 100 ug ml-1 | Minimal inhibitory concentration agianst Candida albicans | ChEMBL. | 9632355 |
MIC (functional) | > 100 ug ml-1 | Minimal inhibitory concentration agianst Saccharomyces cerevisiae | ChEMBL. | 9632355 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.